BRIEF

on Adesso AG (ETR:ADN1)

Adesso SE Reports 13% Sales Growth in Q1 2026

Stock price chart of Adesso AG (EBR:ADN1) showing fluctuations.

Adesso SE experienced a 13% increase in sales, reaching EUR 398.1 million in the first quarter of 2026. This growth, primarily organic, occurred in a challenging economic environment. The company's EBITDA rose to EUR 27.0 million, significantly higher than last year's EUR 17.1 million, driven by improved operational efficiency.

Despite subdued capacity utilisation early in the year, Adesso expanded its full-time workforce by 10% to 11,497. Staff costs increased by 12%, while material costs rose disproportionately by 16% due to reliance on external contractors. In contrast, personnel costs per FTE rose moderately by 1%.

Sales growth was notably strong in the "Utilities" and "Insurance" sectors, with increases of 31% and 30%, respectively. Revenue from Germany accounted for 83% of total sales, reflecting a 13% increase. The international market saw a 15% revenue boost, with Switzerland showing significant recovery.

Looking ahead, Adesso remains optimistic about demand for digitalisation projects, maintaining its forecast of EUR 1.6 to 1.7 billion in sales and EBITDA of EUR 130 to 150 million for the year. Although the macroeconomic outlook is cautious, the company expects improved capacity utilisation.

R. E.

Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.

Click here to consult the press release on which this article is based

See all Adesso AG news